Picture of Star Combo Pharma logo

S66 — Star Combo Pharma News Story

0.000.00%
au flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapContrarian

Australia's Star Combo Pharma hits 10-1/2-month high on Bio-E acquisition

** Shares of nutritional products maker Star Combo Pharma
Ltd  S66.AX  surge as much as 32.1% to A$0.925, their highest
since Aug 24, 2018
    ** Co signs an agreement to acquire organic drinks and
beauty products maker Bio-E Australia Pty Ltd for A$60 mln
($41.89 mln)  urn:newsml:reuters.com:*:nFWN246095
    ** Consideration comprises combination of A$42 mln in cash
and 30 mln of co's shares at an issue price of A$0.60 per share
    ** To fund the acquisition, co intends to undertake a
capital raising of up to A$51 mln at A$0.55 per share 
    ** Stock posts biggest intraday pct gain since Feb 7
    ** Nearly 800,000 shares change hands, which is nearly 24
times the 30-day average volume of about 32,000 shares
    ** Stock up almost 24% this year, as of last close

($1 = 1.4323 Australian dollars)

 ((Anushka.Trivedi@thomsonreuters.com ; +918067491413; Reuters
Messaging: anushka.trivedi.thomsonreuters.com@reuters.net))

Recent news on Star Combo Pharma

See all news